drugset
drugset / Trial / NCT05938452

Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects

NCT05938452 ↗

Phase 1 Completed 40 enrolled Forest Hills Lab Liberyx Therapeutics Ltd. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is designed to assess the safety and PK/PD of GTB and Benzoic Acid (Benzoate) using a single ascending dose (SAD) study (under fasting conditions).

Timeline

Start
2022-12-12
Primary completion
2023-10-19
Completion
2023-10-19

Drugs

EvaluationDrugModalityDoseRoute
Subject TRIBENZOIN Small molecule — Oral

Indications

nervous system disorder